Hierbas pre operatorias en cirugía plastica

Uso perioperatorio de hierbas, medicamentos complementarios y sin receta en pacientes de cirugía plástica Perioperative use of herbal, complementary, and over the counter medicines in plastic surgery patients. Collins D, Oakey S, Ramakrishnan V. St Andrew's Centre for Burns and Plastic Surgery, Court Road, Broomfield, Chelmsford, Essex, United Kingdom. Eplasty. 2011;11:e27. Epub 2011 May 19.Abstract Objective: Over the last 50 years, there has been a surge of interest by both the public and medical practitioners in therapies and disciplines that are not considered part of mainstream medical care. The title given to these is complementary and alternative medicine. Of all these branches, our interest is the increasing use of herbal medicines, traditional medicines (such as Chinese or Indian), homeopathy and "dietary supplements," and the influence they may have on our practice. Our objective was to examine the prevalence and reasons for use of complementary and alternative medicines, the current regulations, and proposed policy changes affecting the licensing of these products. In addition, we highlight some of the problems that have been experienced with herbal and traditional medicines. Methods: A prospective analysis of herbal and over the counter medicines used by elective plastic surgery patients. Results: Of 100 elective plastic surgery patients undergoing procedures at St Andrew's Centre for Burns and Plastic Surgery, 44% of patients were taking a dietary supplement, herbal, or homeopathic remedy. In none of the patients was this documented in the notes by either the surgeon or anesthetist. Conclusions: We recommend that clear documentation of the use of nonprescribed medicines becomes part of standard practice and, furthermore, that patients stop all such medications 2 weeks prior to surgery until the efficacy, interactions, and safety profiles are clearly established http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3098682/pdf/eplasty11e27.pdf Fitoterapéutica: evaluación del potencial de 1000 plantas. Phytotherapeutics: an evaluation of the potential of 1000 plants. Cravotto G, Boffa L, Genzini L, Garella D. Dipartimento di Scienza e Tecnologia del Farmaco, University of Turin, Turin, Italy. giancarlo.cravotto@unito.it J Clin Pharm Ther. 2010 Feb;35(1):11-48. Abstract OBJECTIVE: The aim of this review is to evaluate and summarize the available scientific information on the commonest plant extracts marketed in Western countries. In view of the intense, ongoing search for new plant extracts with powerful anti-inflammatory activity, we paid particular attention to this topic. The aim is to provide broad coverage of as many potentially useful plants as possible and then to focus on those with the greatest therapeutic potential. METHODS: Our bibliographic sources were the SciFinder databases: CAPLUS, MEDLINE, REGISTRY, CASREACT, CHEMLIST, CHEMCATS (update to October 2007). In order to assess the value of clinical trials, we focused a specific search on clinical investigations concerning nine plants with the most trial data, viz., Althaea officinalis, Calendula officinalis, Centella asiatica, Echinacea purpurea, Passiflora incarnata, Punica granatum, Vaccinium macrocarpon, Vaccinium myrtillus, Valeriana officinalis. This was carried out in several databases (update to June 2008): ISI Web of Knowledge(SM) (ISI WoK), SciFinder (CAPLUS, MEDLINE, REGISTRY, CASREACT, CHEMLIST, CHEMCATS) and PubMed (indexed for MEDLINE). RESULTS: Our survey covers roughly a 1000 plants, although clinical trials have been published only for 156 plants supporting specific pharmacological activities and therapeutic applications. However, for about half of the plants, in vitro and in vivo studies provide some support for therapeutic use. For one-fifth of the plants included in our search, only phytochemical studies were found. Their properties and indications were often attributed to the presence of certain compounds, but no evidence concerning the activities of the whole extracts was presented. We found that for about 12% of the plants, currently available on the Western market, no substantial studies on their properties had been published, while there was strong evidence that 1 in 200 were toxic or allergenic, so that their use ought to be discouraged or forbidden. Nine plants had considerable evidence of therapeutic effect, viz., A. officinalis, Calendula officinalis, Centella asiatica, E. purpurea, Passiflora incarnata, Punica granatum, Vaccinium macrocarpon, Vaccinium myrtillus, Valeriana officinalis. CONCLUSION: The present review provides a baseline on the level of evidence available on many herbal preparations and should be of help to those intending to research further on these topics. http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2710.2009.01096.x/pdf

Atentamente Dr. Benito Cortes-Blanco Anestesiología y Medicina del Dolor www.anestesia-dolor.org